Oncology

Prostate Cancer

Expert Perspectives in Prostate Cancer to Cover Key Topics in Prostate Cancer Treatment

expert perspectives by Tanya B. Dorff, MD; Neal D. Shore, MD, FACS; Robert Dreicer, MD, MS, MACP, FASCO

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Prostate Cancer will feature selected topics in Prostate Cancer that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts:

Tanya B. Dorff, MD

Associate Professor, Department of Medical Oncology & Therapeutics Research
Section Chief, Genitourinary Disease Program
City of Hope
Duarte, CA

Robert Dreicer, MD, MS, MACP, FASCO

Section Head, Medical Oncology
Deputy Director, University of Virginia Comprehensive Cancer Center
Associate Director for Clinical Research
Co-Director, Paul Mellon Urologic Cancer Institute
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, VA

Neal D. Shore, MD, FACS

Director, CPI, Carolina Urologic Research Center
Chief Medical Officer, Urology/Surgical Oncology
GenesisCare, US
Myrtle Beach, SC

Community-Selected Topics:

Expert Roundtables

•   Combinatorial Strategies in Targeting Metastatic Castration-Resistant Prostate Cancer
•   High-Risk Prostate Cancer: Implications of Entering a More Molecular, More Genomic Era
•   Prostate Cancer: Avoiding Overtreatment and Undertreatment in the Current Era
•   Therapeutic Sequencing in View of Prostate Cancer Biology

Clinical Topic Updates

•   Co-Inhibition and Co-Targeting in Advanced Prostate Cancer
•   Next-Generation Imaging and Curative-Intent Metastasis-Directed Therapies
•   Noninvasive Profiling of Advanced Prostate Cancer
•   Prostate-Specific Membrane Antigen–Positive Metastatic Castration-Resistant Prostate Cancer

Patient Care Perspectives

•   Adherence to Oral Therapies for Advanced Prostate Cancer
•   Clinical Trial Design Innovation and Incorporation of Patient Views
•   Novel Antiandrogens and Treatment Intensification for Prostate Cancer
•   Quality-Adjusted Survival in Metastatic Castration-Resistant Prostate Cancer